Allergan's results miss on two fronts
Revenues of US$3.32bn, up 4.4%, came in some US$400mln shy of forecasts
Company
Allergan
NYSE:AGN
Allergan is a global specialty pharmaceutical company, which develops and commercialises products for eye care, neuromodulator, skin care and other specialty markets. Its products are sold in over 100 countries worldwide and include the successful and popular Botox and Botox cosmetics treatments.
90 stories · page 3 of 5
Investments and investor services
FTSE 100 nears May 2015 highs after data and sterling fall
FTSE 100 shares had a good start to the fourth quarter, helped by good manufacturing data and hopes that the pound's sharp fall on Monday will help exporters
Allergan to buy Tobira for US$1.7bn
Allergan wants to gain access to Tobira’s potentially lucrative experimental NASH treatments
Archive
Vitae Pharma downgraded after Allergan takeover offer
Vitae Pharmaceuticals shares may have rocketed by 160% after Allergan said it would buy the company on Wednesday, but brokers at Wedbush downgraded the small stock to neutral and trimmed the share price target to $21
Wall St shares edge lower after oil supply data setback
US stocks edged lower on Wednesday after oil prices sagged on supply data
Tepper tips Allergan, Quorum Health
Hedge fund manager David Tepper increased his stake in the drugmaker Allergan and orchestrated a new bet on Quorum Health
Allergan earnings healthy, but revenues slightly anaemic
Company releases numbers soon after major divestitures
Teva corporate bond deal could become year’s 3rd biggest
Teva Pharmaceutical Industries Ltd. is heading towards one of the year’s largest US corporate bond deals as foreign investors stampeded for a piece of the high-quality paper
Trending: Brexit seen as a lever to more transatlantic M&A
When Brexit was first mooted by the Leave camp over a year ago, the slogan was all about taking back control of sovereignty and executive powers from the European Union. No one ever saw it as a conduit for taking control of US companies, di
US shares close higher as energy stocks perk up on pared oil price losses
US energy shares helped solidify Wall Street gains by the close on Tuesday – after earlier strife over the uncertainty contained in Fed chair Janet Yellen’s testimony on Capitol Hill - leaving the S&P 500 to notch its second straight day of
US stocks cling onto gains but unimpressed by Yellen’s outlook
Wall Street shares were clinging onto gains at midsession on Tuesday, underwhelmed by the lack of certainty in the Federal Reserve’s economic and monetary outlook after the central bank’s chair Janet Yellen read testimony before the US Sena
Impax splashes out $586mln on Allergan and Teva's generics cast-offs
Teva, which is taking over Allergan, has been ordered to sell some of Allergan's US generic drugs assets
US stocks shift higher ahead of Yellen speech
Stocks are adding to yesterday's gains, though not as briskly as had been expected before the market opened
US stocks shift higher ahead of Yellen speech
Stocks are adding to yesterday's gains, though the indices have not risen as high as had been expected ahead of the open
Pharma Pfizer unfazed after Jefferies trims price target
Pharmaceuticals behemoth Pfizer Inc shares remained resilient after broker Jefferies trimmed its price target on the pharmaceutical giant's stock to $42 from $40, as Pfizer leadership prepares to decide whether to separate its global establ
Not tonight; he's got a headache
"It's important to encourage everyone – men and women – who is experiencing symptoms to seek an accurate diagnosis."
Trending: Macys, Staples and the worst Wall Street M&A year on record
If the oil and commodities sectors have had a rough ride this year, traders' shun words on Wednesday on Wall Street were Macys, Staples, and retail as US faces up to worst M&A deal failures on record
Hardware & electrical equipment
Trending: Banking on Apple in Canada
While Facebook applied two years ago for a banking licence in the United States and has since begun developing initiatives to offer methods for its users to store cash and pay for services via the social network, Apple is formalising relati
Allergan shares rise after $10bn buyback plan
Allergan shares rise after the company says it will buy back up to $10bn in stock following a swing to a first-quarter profit on a surge in sales of key drugs, including the wrinkle and muscle spasm treatment Botox
US investors sit on their hands ahead of Fed minutes
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger